The association between fructosamine-3 kinase 900C/G polymorphism, transferrin polymorphism and human herpesvirus-8 infection in diabetics living in South Kivu

Acta Tropica

Volumn 163, Issue , 2016, Pages 14-19

  Cikomola, Justin C ^a,b   Vandepoele, Karl ^b   Katchunga, Philippe B ^a   Kishabongo, Antoine S ^a   Padalko, Elizaveta Y ^b   Speeckaert, Marijn M ^b   Delanghe, Joris R ^b  

^a CATHOLIC UNIVERSITY OF BUKAVU   (Democratic Republic Congo)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Diabetes meliitus; Ferroportin Q248H mutation; Fructosamine 3 kinase 900C G polymorphism; Human herpes virus 8; TF polymorphism

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; CATION TRANSPORT PROTEIN; FRUCTOSAMINE-3-KINASE; METAL TRANSPORTING PROTEIN 1; PHOSPHOTRANSFERASE; TRANSFERRIN;

ANTIBODY; DIABETES; GENOTYPE; MUTATION; PHENOTYPE; POLYMORPHISM; VIRUS;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONGO; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FERROPORTIN GENE; FN3K GENE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HERPES VIRUS INFECTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN HERPESVIRUS 8; INFECTION RATE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; TRANSFERRIN GENE; WILD TYPE; CASE CONTROL STUDY; COMPLICATION; DEMOCRATIC REPUBLIC CONGO; GENETICS; GENOTYPE; HERPESVIRIDAE INFECTIONS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; VIROLOGY;

DEMOCRATIC REPUBLIC CONGO; KIVU;

HUMAN HERPESVIRUS 8;

ADULT; AGED; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; DEMOCRATIC REPUBLIC OF THE CONGO; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, GENETIC; PREVALENCE; REGRESSION ANALYSIS; TRANSFERRIN;

EID: 84979536495     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2016.07.011     Document Type: Article

References (50)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 35 (2012), S64–S71.
2. Albuquerque, D., Manco, L., Loua, K.M., Arez, A.P., Trovoada, M.J., Relvas, L., Millimono, T.S., Rath, S.L., Lopes, D., Nogueira, F., Varandas, L., Alvarez, M., Ribeiro, M.L., SLC40A1 Q248H allele frequencies and associated SLC40A1 haplotypes in three West African Population samples. Ann. Hum. Biol. 38 (2011), 378–381.
3. Buysschaert, M., Paris, I., Selvais, P., Hermans, M.P., Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking Belgium. Diabetes Metab. 23 (1997), 308–313.
4. Caselli, E., Rizzo, R., Ingianni, A., Contini, P., Pompei, R., Di Luca, D., High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in sardinian patients with type 2 diabetes mellitus. J. Med. Virol. 86 (2014), 1745–1751.
5. Cavalli-Sforza, L., Menozzi, P., Piazza, A., The History and the Geography of Human Genes. 1994, Princeton University Press, Princeton, NJ, 188.
6. Collard, G., Delpierre, G., Stroobant, V., Matthijs, G., Van Schaftingen, E., A mammalian protein homologous to fructosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines. Diabetes 52 (2003), 2888–2895.
7. Dedicoat, M., Newton, R., Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br. J. Cancer 88 (2003), 1–3.
8. Defrère, S., González-Ramos, R., Lousse, J.C., Colette, S., Donnez, J., Van Langendonckt, A., Insights into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol. Histopathol. 26 (2011), 1083–1092.
9. Delpierre, G., Veiga-da-Cunha, M., Vertommen, D., Buysschaert, M., Van Schaftingen, E., Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. Diabetes Metab. 32 (2006), 31–39.
10. Dmochowski, K., Finegood, D.T., Francombe, W., Tyler, B., Zinman, B., Factors determining glucose tolerance in patients with thalassemia major. J. Clin. Endocrinol. Metab. 77 (1993), 478–483.
11. Donovan, A., Lima, C.A., Pinkus, J.L., Pinkus, G.S., Zon, L.I., Robine, S., Andrews, N.C., The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell. Metab. 1 (2005), 191–200.
12. Fritz, G., RAGE: a single receptor fits multiple ligands. Trends Biochem. Sci. 36 (2011), 625–632.
13. Giblett, E.R., Hickman, C.G., Smithies, O., Serum transferrins. Nature 183 (1959), 1589–1590.
14. Gordeuk, V.R., Caleffi, A., Corradini, E., Ferrara, F., Jones, R.A., Castro, O., Onyekwere, O., Kittles, R., Pignatti, E., Montosi, G., Garuti, C., Gangaidzo, I.T., Gomo, Z.A.R., Moyo, V.M., Rouault, T.A., MacPhail, P., Pietrangelo, A., Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol. Dis. 31 (2003), 299–304.
15. Gordeuk, V.R., Diaz, S.F., Onojobi, G.O., Kasvosve, I., Debebe, Z., Edossa, A., Pantin, J.M., Xiong, S., Nekhai, S., Nouraie, M., Tsukamoto, H., Taylor, R.E., Ferroportin Q248H, dietary iron and serum ferrintin in community African Americans with low to high alcohol consumption. Alcohol Clin. Exp. Res. 32 (2008), 1947–1953.
16. Hang, H., Hongfei, J., Haitao, R., Xinlei, H., Xingang, W., Chunmao, H., AGEs and chronic subclinical inflammation in diabetes: disorders of immune system. Diabetes Metab. Res. Rev. 31 (2015), 127–137.
17. Ingianni, A., Carta, F., Reina, A., Manai, M., Desogus, A., Pompei, R., Prevalence of herpesvirus 8 infection in type 2 diabetes mellitus patients. Am. J. Infect. Dis. 3 (2007), 123–127.
18. Ingianni, A., Piras, E., Laconi, S., Angius, F., Batetta, B., Pompei, R., Latent herpesvirus 8 infection improves both insulin and glucose uptake in primary endothelial cells. New Microbiol. 36 (2013), 257–265.
19. Johnson, E.E., Sandgren, A., Cherayil, B.J., Murray, M., Wessling-Resnick, M., Role of ferroportin in macrophage-mediated immunity. Infect. Immun. 78 (2010), 5099–5106.
20. Kamboh, M.I., Ferrell, R.E., Human transferrin polymorphism. Hum. Hered. 37 (1987), 65–81.
21. Kasvosve, I., Delanghe, J., Gomo, Z., Gangaidzo, I.T., Khumalo, H., Wuyts, B., Mvundura, E., Saungweme, T., Moyo, V.M., Boelaert, J.R., Gordeuk, V.R., Transferrin polymorphism influences iron status in blacks. Clin. Chem. 46 (2000), 1535–1539.
22. Kasvosve, I., Delanghe, J.R., Gomo, Z.A.R., Gangaidzo, I.T., Khumalo, H., Langlois, M.R., Moyo, V.M., Saungweme, T., Mvundura, E., Boelaert, J.R., Gordeuk, V.R., Effect of transferrin polymorphism on the metabolism of vitamin C in Zimbabwean adults. Am. J. Clin. Nutr. 75 (2002), 321–325.
23. Kasvosve, I., Gomo, Z.A.R., Nathoo, K.J., Matibe, P., Mudenge, B., Loyevsky, M., Gordeuk, V.R., Effect of ferroportin Q248 H polymorphism on iron status in African children. Am. J. Clin Nutr. 82 (2005), 1102–1106.
24. Kasvosve, I., Debebe, Z., Nekhai, S., Gordeuk, V.R., Ferroportin (SLC40A1) Q248 H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children. Clin. Chim. Acta 411 (2010), 1248–1252.
25. Kasvosve, I., Tshwenyego, U., Phuthego, T., Koto, G., Zachariah, M., Nyepetsi, N.G., Motswaledi, M.S., Serum ferritin concentration is affected by ferroportin Q248H mutation in Africans. Clin. Chim. Acta 444 (2015), 257–259.
26. Kasvosve, I., Effect of ferroportin polymorphism on iron status and infection. Clin. Chim. Acta 416 (2013), 20–25.
27. Katchunga, P.B., Baguma, M., M'Buyamba-Kabangu, J.R., Philippé, J., Hermans, M.P., Delanghe, J.R., Ferroportin Q248H mutation, hyperferritinemia and atypical type 2 diabetes mellitus in South Kivu. Diabetes Metab. Syndr. 7 (2013), 112–115.
28. Masaisa, F., Breman, C., Gahutu, J.B., Mukiibi, J., Delanghe, J., Philippé, J., Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women. Ann. Hematol. 91 (2012), 911–916.
29. Mayr, R., Janecke, A.R., Schranz, M., Griffiths, W.J., Vogel, W., Pietrangelo, A., Zolller, H., Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J. Hepatol. 53 (2010), 941–949.
30. Mohás, M., Kisfali, P., Baricza, E., Mérei, A., Maasz, A., Cseh, J., Mikolas, E., Szijarto, I.A., Melegh, B., Wittmann, I., A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c Levels and the onset of type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 118 (2010), 209–212.
31. Monnier, V.M., The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging. Biochem. J. 399 (2006), e11–13.
32. Mosca, L., Penco, S., Patrosso, M.C., Marrocchi, A., Lapolla, A., Sartore, G., Chilelli, N.C., Paleari, R., Mosca, A., Genetic variability of the fructosamine 3-kinase gene in diabetic patients. Clin. Chem. Lab. Med. 49 (2011), 803–808.
33. Nekhai, S., Xu, M., Foster, A., Kasvosve, I., Diaz, S., Machado, R.F., Castro, O.L., Kato, G.J., Taylor, J.G., Gordeuk, V., Reduced sensitivity of the ferroportin Q248H mutant to physiologic concentrations of hepcidin. Haematologica 98 (2013), 455–463.
34. Nemeth, E., Valore, E.V., Territo, M., Schiller, G., Lichtenstein, A., Ganz, T., Hepcidin, a putative mediator of inflammation, is a type II acute-phase protein. Blood 101 (2003), 2461–2463.
35. Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T., Kaplan, J., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004), 2090–2093.
36. Ott, C., Jacobs, K., Haucke, E., Santos, A.N., Grune, T., Simm, A., A Role of advanced glycation end products in cellular signaling. Redox Biol. 2 (2014), 411–429.
37. Pietrangelo, A., The ferroportin disease. Blood Cells Mol. Dis. 32 (2004), 131–138.
38. Rajpathak, S.N., Crandall, J.P., Wylie-Rosett, J., Kabat, G.C., Rohan, T.E., Hu, F.B., The role of iron in type 2 diabetes in humans. Biochim. Biophys. Acta 1790 (2009), 671–681.
39. Rivers, C.A., Barton, J.C., Gordeuk, V.R., Acton, R.T., Speechley, M.R., Snively, B.M., Leiendecker-Foster, C., Press, R.D., Adams, P.C., McLaren, G.D., Dawkins, F.W., MacLaren, C.E., Reboussin, D.M., Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol. Dis. 38 (2007), 247–252.
40. Rose, P.P., Carroll, J.M., Carroll, P.A., DeFilippis, V.R., Lagunoff, M., Moses, A.V., Roberts, C.T., Fruh, K., The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma. Oncogene 26 (2007), 1995–2005.
41. Schulz, T.F., Kaposi's sarcoma-associated herpes-virus (human herpesvirus 8): epidemiology and pathogenesis. J. Antimicrob. Chemother. 45 (2000), 15–27.
42. Schwager, J., Bompard, A., Weber, P., Raederstorff, D., Ascorbic acid modulates cell migration in differentiated HL-60 cells and peripheral blood leukocytes. Mol. Nutr. Food Res. 00 (2015), 1–11.
43. Simonart, T., Iron: a target for the management of Kaposi's sarcoma?. BMC Cancer 4 (2004), 1–8.
44. Smithies, O., Hiller, O., The genetic control of transferrins in humans. Biochem. J. 72 (1959), 121–126.
45. Smithies, O., Variations in serum beta-globulins. Nature 180 (1957), 1482–1483.
46. Sobngwi, E., Choukem, S.P., Agbalika, F., Blondeau, B., Fetita, L.S., Lebbe, C., Thiam, D., Cattan, P., Larghero, J., Foufelle, F., Ferre, P., Vexiau, P., Calvo, F., Gautier, J.F., Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans. J. Am. Med. Assoc. 299 (2008), 2770–2776.
47. Sun, Q., Zachariah, S., Chaudhary, P.M., The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J. Biol. Chem. 278 (2003), 52437–52445.
48. Szwergold, B.S., Howell, S., Beisswenger, P.J., Human fructosamine-3-kinase. Purification, sequencing, substrate specificity, and evidence for activity in vivo. Diabetes 50 (2001), 2139–2147.
49. Weissmann, A., Linn, S., Weltfriend, S., Friedman-Birnbaum, R., Epidemiological study of classic Kaposi's sacoma: a retrospective review of 125 cases from Northern Israel. J. Eur. Acad. Dermatol. Venereol. 14 (2000), 91–95.
50. Ziegler, J.L., Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 342 (1993), 1348–1351.